147 related articles for article (PubMed ID: 15343177)
1. Ethical issues in newborn screening research: lessons from the Wisconsin cystic fibrosis trial.
Taylor HA; Wilfond BS
J Pediatr; 2004 Sep; 145(3):292-6. PubMed ID: 15343177
[No Abstract] [Full Text] [Related]
2. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
Dhondt JL
J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772
[TBL] [Abstract][Full Text] [Related]
3. [Neonatal screening of cystic fibrosis: diagnostic and ethical problems with mild mutations].
Roussey M; Le Bihannic A; Audrezet MP; Blayau M; Dagorne M; Deneuville E; Férec C; Journel H; Moisan-Petit V; Rault G; Scotet V; Storni V; Vigneron P
Arch Pediatr; 2005 Jun; 12(6):650-3. PubMed ID: 15904758
[No Abstract] [Full Text] [Related]
4. Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
Farrell PM
Adv Pediatr; 2000; 47():79-115. PubMed ID: 10959441
[No Abstract] [Full Text] [Related]
5. [Cystic fibrosis and neonatal screening].
Nau JY
Rev Med Suisse; 2007 May; 3(110):1212. PubMed ID: 17564353
[No Abstract] [Full Text] [Related]
6. Population screening in the age of genomic medicine.
Khoury MJ; McCabe LL; McCabe ER
N Engl J Med; 2003 Jan; 348(1):50-8. PubMed ID: 12510043
[No Abstract] [Full Text] [Related]
7. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
Bishop Hubbard H
Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
[TBL] [Abstract][Full Text] [Related]
8. Newborn blood collections. Science gold mine, ethical minefield.
Couzin-Frankel J
Science; 2009 Apr; 324(5924):166-8. PubMed ID: 19359558
[No Abstract] [Full Text] [Related]
9. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
Lee DS; Rosenberg MA; Peterson A; Makholm L; Hoffman G; Laessig RH; Farrell PM
J Pediatr; 2003 Jun; 142(6):617-23. PubMed ID: 12838188
[TBL] [Abstract][Full Text] [Related]
10. Information flow after a positive newborn screening for cystic fibrosis.
Dillard JP; Tluczek A
J Pediatr; 2005 Sep; 147(3 Suppl):S94-7. PubMed ID: 16202792
[TBL] [Abstract][Full Text] [Related]
11. Newborn screening for cystic fibrosis. The Cystic Fibrosis Neonatal Screening Study Group.
Farrell PM; Mischler EH
Adv Pediatr; 1992; 39():35-70. PubMed ID: 1442316
[TBL] [Abstract][Full Text] [Related]
12. MN Supreme Court rules on newborn screening samples.
Minn Med; 2011 Dec; 94(12):18-9. PubMed ID: 22372040
[No Abstract] [Full Text] [Related]
13. Genetic screening as a technique of government: the case of neonatal screening for cystic fibrosis in France.
Vailly J
Soc Sci Med; 2006 Dec; 63(12):3092-101. PubMed ID: 16956705
[TBL] [Abstract][Full Text] [Related]
14. Lessons from the residual newborn screening dried blood sample litigation.
Lewis MH
J Law Med Ethics; 2015; 43 Suppl 1():32-5. PubMed ID: 25846160
[No Abstract] [Full Text] [Related]
15. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma.
Fost N; Farrell PM
Clin Res; 1989 Sep; 37(3):495-500. PubMed ID: 2673641
[No Abstract] [Full Text] [Related]
16. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States.
Wilfond BS; Gollust SE
J Pediatr; 2005 May; 146(5):668-74. PubMed ID: 15870672
[TBL] [Abstract][Full Text] [Related]
17. Currents in contemporary ethics: the role of parents in expanded newborn screening.
Harrell H
J Law Med Ethics; 2009; 37(4):846-51. PubMed ID: 20122121
[No Abstract] [Full Text] [Related]
18. Neonatal screening, new technologies, old and new legal concerns.
Abbing HD
Eur J Health Law; 2004 Jun; 11(2):129-37. PubMed ID: 15387421
[No Abstract] [Full Text] [Related]
19. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
Massie J; Clements B;
Pediatr Pulmonol; 2005 May; 39(5):440-6. PubMed ID: 15704202
[TBL] [Abstract][Full Text] [Related]
20. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.
Kloosterboer M; Hoffman G; Rock M; Gershan W; Laxova A; Li Z; Farrell PM
Pediatrics; 2009 Feb; 123(2):e338-46. PubMed ID: 19171585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
